Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related IMGN
ImmunoGen Announces Recent Product Program Advancements and Anticipated 2016 Events in Advance of J.P. Morgan Healthcare Conference
Buy ImmunoGen On Transformational Products, Jefferies Says
ImmunoGen to evaluate combo of lead product candidate and Merck's Keytruda in ovarian cancer (Seeking Alpha)
Related CRUS
Benzinga's Top Upgrades
Oppenheimer Upgrades Key Apple Supplier
Apple Chipmakers Skyworks, NXP, Avago Plunge On Qorvo Sales Outlook (Investor's Business Daily)

ImmunoGen (NASDAQ: IMGN) dipped 5.43% to $12.90 in the pre-market session after the company announced a license agreement with Novartis. Morgan Stanley downgraded the stock from Equal-weight to Underweight.

Cirrus Logic (NASDAQ: CRUS) shares dropped 5.62% to $21.00 in pre-market trading. Cirrus Logic shares have dropped 27.88% over the past 52 weeks, while the S&P 500 index has gained 28.30% in the same period.

Randgold Resources (NASDAQ: GOLD) shares fell 1.72% to $75.28 in the pre-market trading. Randgold's PEG ratio is 6.04.

Facebook (NASDAQ: FB) dipped 0.78% to $47.16 after weak user data made investors nervous about the company's future.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (CRUS + FB)

View Comments and Join the Discussion!

Get Benzinga's Newsletters